Markus Puhlmann bought $35K of CATX stock
By AlphaYouPublished Form 4
Puhlmann Markus
Reporting filer
Markus Puhlmann reported buying 41,000 shares of Perspective Therapeutics, Inc. for about $35K ($0.84 a share on average). Form 4 filed Nov 13, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Nov 13, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Puhlmann Markus | 2026-11-11 | P | Purchase | 6000 | 0.83 | 143,542 | 2 days | Filed terms
|
| Common Stock | Puhlmann Markus | 2026-11-12 | P | Purchase | 35000 | 0.8447 | 178,542 | 1 day | Filed terms
|
Common Stock
- Owner
- Puhlmann Markus
- Date
- 2026-11-11
- Code
- P
- Action
- Purchase
- Quantity
- 6000
- Price
- 0.83
- Following holdings
- 143,542
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 6000
- transaction Price Per Share: 0.83
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 143542
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Puhlmann Markus
- Date
- 2026-11-12
- Code
- P
- Action
- Purchase
- Quantity
- 35000
- Price
- 0.8447
- Following holdings
- 178,542
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 35000
- transaction Price Per Share: 0.8447
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 178542
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Puhlmann Markus: Chief Medical Officer.
- F1: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8408 to $0.8450, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.